Business Development

 

Changing market needs, competitive pressures, the need to fill new product pipelines and increased investor expectations is leading to changing business models at all stages of bioscience and pharmaceutical company growth. The larger pharmaceutical companies faced with patent expirations and decreasing product pipelines are looking for new avenues to sustain growth. Smaller bioscience companies need investment, large company know how and infrastructure to bring products to market. This dynamic has led to the increasing importance of strategic alliances and partnering within the broader healthcare industry.

 

JasTech specialises in advising clients acquiring or divesting products, technologies or businesses on the timing, choice of partner and negotiating the right deal throughout the continuum of partnership deals including:

 

         Scientific or commercial collaborations

         Out-sourcing production , sales, R&D or clinical/market trials

         In-licensing

         Out-licensing

         Divestments

         Mergers and Acquisitions

 

Please contact us for more information on how we could assist you.